Literature DB >> 12923276

Is the recommended dose of leflunomide the best regimen to treat rheumatoid arthritis patients?

A Erra, C Tomas, P Barcelo, M Vilardell, S Marsal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12923276     DOI： 10.1093/rheumatology/keg292

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  1 in total

1.  Treatment of Crohn's disease with leflunomide as second-line immunosuppression : a phase 1 open-label trial on efficacy, tolerability and safety.

Authors:  Martin H Holtmann; Anna-Lena Gerts; Arndt Weinman; Peter R Galle; Markus F Neurath
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.